DEPLOYDatabase

Robot model

EksoNR

exoskeletoncommercialby Ekso Bionics

Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury).

Track EksoNR
Manufacturer
Ekso Bionics
Form factor
exoskeleton
Maturity
commercial
Lifecycle
active
Deployments
4
Website
eksobionics.com ↗

The verified answer

As of Sep 2026, DEPLOY verifies EksoNR, a exoskeleton by Ekso Bionics (commercial): 4 verified deployments on record. 3 sources back the record.

Regulatory status1 FDA 510(k) clearance

EksoNR holds 1 FDA 510(k) clearance, per the DEPLOY registry.

See all 1 filings

Overview

Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury). User intent plus weight-shift triggers powered steps; the device powers the joints, the clinician/patient sets the session. FDA cleared.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Type

Exoskeleton for neurorehabilitation

Specs

Use

medical rehab

Control

weight-shift + user intent triggers powered steps

Powered

yes (motor-driven)

Runtime

8 h

Weight kg

25

Regulatory

FDA cleared

Body region

lower-limb

Availability

commercial

Data & sources

Press releases

1

Web sources

2

3 sources backing this record.View all →

Pricing

No verified price is on record for EksoNR. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (4)

  • EksoNR at Multiple, USAoperational

    EksoNR exoskeleton deployed in rehabilitation centers for SCI, stroke, and brain injury patients.

  • EksoNR at Multiple, USAoperational

    Ekso Indego Personal — lightest weight exoskeleton available for home and community use.

  • EksoNR at Germanyoperational

    Ekso Bionics maintains a distribution and service facility in Ratingen, Germany to serve the EMEA market.

  • EksoNR at United Statesoperational

    EksoNR is FDA-cleared for stroke, SCI, acquired brain injury, and multiple sclerosis (first exoskeleton cleared for MS, June 2022).

Free to use on your site, with a link back to DEPLOY.

EksoNR on the deployment map

View the global map

Where EksoNR is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Deployment-verified media (1)

PRIMARY SOURCE
Courtesy of Ekso Bionics

Ekso Bionics footage of a stroke patient performing clinician-supervised assisted stepping in the EksoNR rehabilitation exoskeleton. The device provides adaptive assistance and the patient initiates each step (the robot does not walk the patient), so it is not autonomous.

From deployment: Germany

Regulatory filings (1)

Safety record

2 incidents on record (1 moderate, 1 minor). Most recent: Apr 2023.

moderate
1
minor
1

Most recent: Apr 2023

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Incidents affecting EksoNR (2)

Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Sources (3)

  1. https://en.wikipedia.org/wiki/Ekso_Bionics
  2. https://www.eksobionics.com/
  3. https://eksobionics.com/eksonr/

Common questions

What is EksoNR?
Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury). User intent plus weight-shift triggers powered steps; the device powers the joints, the clinician/patient sets the session. FDA cleared.
How much does EksoNR cost?
EksoNR's price is not publicly disclosed. DEPLOY has no verified price on record for EksoNR from Ekso Bionics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is EksoNR actually deployed in the real world?
Yes. EksoNR is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
What are the specs of EksoNR?
EksoNR's recorded specifications on the DEPLOY registry: Runtime: 8 h; Weight: 25 kg. See the Specs section for the full sourced set.
Who makes EksoNR?
EksoNR is made by Ekso Bionics, based in Richmond, California, USA, founded in 2005.
Where is EksoNR deployed?
4 verified deployments of EksoNR are on the DEPLOY registry, including at Multiple, USA, Germany, United States.
Can you buy EksoNR?
EksoNR is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
Is EksoNR FDA cleared?
EksoNR has 1 regulatory record on the DEPLOY registry: FDA 510(k) clearance (K143690), cleared. See the Regulatory filings section for each agency source.
What are alternatives to EksoNR?
On the DEPLOY registry, comparable exoskeleton robots to EksoNR include Ant-H1 Pro, Cyberdyne HAL, German Bionic Cray X, HANK.
How does EksoNR compare to Ant-H1 Pro?
EksoNR and Ant-H1 Pro (Kenqing Technology · 5 deployments) are both exoskeleton robots on the DEPLOY registry. EksoNR has 4 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is EksoNR a top exoskeleton?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, EksoNR ranks in roughly the top 28% of exoskeleton models tracked by the registry.
What is EksoNR's maturity stage?
EksoNR is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is EksoNR safe?
EksoNR has 2 active incidents on record in the DEPLOY registry. 2 incidents on record (1 moderate, 1 minor). Most recent: Apr 2023. Retracted incidents are excluded from this count.
What is the EksoNR exoskeleton?
EksoNR is the first exoskeleton FDA-cleared for stroke, spinal cord injury, and acquired brain injury rehabilitation. It is also the only exoskeleton FDA-cleared for multiple sclerosis. EksoNR is backed by over 200 published articles and is designed for use in clinical rehabilitation settings.
Ekso Bionics: EksoNR Holy Cross: EksoNR
Methodology: Verified · 3 sources (1 primary) · last reviewed 2026-07-15

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-15

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1
knowledge-base
Knowledge base
1
unclassified
Unclassified source
1
primary-company-ir
Company IR disclosure

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for EksoNR.

Recent coverage

EksoNR in third-party press

EKSO stock stays anchored by Ekso Bionics' rehab robotics - Ad Hoc News

Jul 9, 2026

Ekso Bionics introduces EksoNR exoskeleton for neurorehabilitation - The Robot Report

Aug 15, 2019